Please Wait.....
Report
Gene editing Market Research Report Forecast to 2030
Market Report I 2023-08-23 I 120 Pages I Market Research Future
Gene editing Market Research Report Forecast to 2030
Market Overview
The Gene editing Market size is projected to register a CAGR of 20.9% during the forecast period. The developing number of key drives and expanding subsidizing for genetic exploration are main considerations driving the market development.
Genomic editing alludes to the procedures and methods used to alter the genetic data of any living life form. Genome editing includes the alteration of genes in numerous areas utilizing recombinant innovation, which increments addition accuracy and diminishes cell poisonousness. An assortment of innovations permits researchers to modify a creature's DNA. These advancements empower adding, erasing, or changing genetic material at explicit areas inside the genome. Ascend in the quantity of key drives as consolidations, acquisitions, item endorsement, coordinated efforts, and organizations to acquire an upper hand and proposition progressed treatment choices for genomic editing.
Market Segmentation
Technology-based segments of the gene editing market include CRISPR, TALEN, ZFN, antisense, and others.
Genetic engineering, gene therapy, cell line engineering, and other applications make up the market segments of gene editing.
Gene editing market segmentation is based on biotechnology and pharmaceutical firms, contract research organizations (CROs), university & government research institutes, and contract research organizations (CROs).
Regional Insights
The North American gene editing market is supposed to represent over USD 2 billion in 2022 and is supposed to show a 21.19% CAGR during the review time frame. This is credited to the expansion of malignant growth and other genetic problems, a developing inclination for customized medication, an expansion in private and public area financing, and quick progressions in sequencing and gene editing innovations are driving the market for gene editing in the North America region.
Europe gene editing market is supposed to represent the second-biggest market share because of mechanical headways in medical services IT like the utilization of Computerized reasoning (man-made intelligence) to fabricate CRISPR frameworks are driving development drive the market development of gene editing in Europe.
The Asia-Pacific gene editing market is supposed to develop at a CAGR of 24.03% from 2023 to 2030. This is because of the rising mechanical leap forwards, a flourishing biotechnology industry in arising regions, and the rising commonness of disease and other genetic irregularities.
The Rest of the World incorporates the Middle East, Africa, and Latin America. Middle East holds the significant market share in the Middle East and Africa region because of a few main considerations, for example, developing government support, rising public-private organizations, and expanded subsidizing are adding to the region's biotechnology industry's development.
Major Players
Key Companies in the Gene editing Market Include GE Healthcare (US), Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Lonza (Switzerland), GenScript (US), Horizon Discovery Ltd (UK), OriGene Technologies, Inc (US), Integrated DNA Technologies, Inc (US), New England Biolabs, Inc (US), and Sangamo Therapeutics (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING FUNDING FOR GENETIC RESEARCH
4.2.2 RISING INCIDENCE OF GENETIC DISORDERS
4.2.3 GROWING NUMBER OF STRATEGIC INITIATIVES
4.3 RESTRAINTS
4.3.1 OFF-TARGET EFFECTS OF CRISPR TECHNOLOGY
4.3.2 HIGH COST OF EQUIPMENT
4.4 OPPORTUNITIES
4.4.1 INCREASING APPLICATION AREAS OF GENE EDITING
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL GENE EDITING MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON REGIONS
5.3.3 IMPACT ON SUPPLY GAP ANALYSIS
5.3.4 IMPACT ON PRICING
6 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 CRISPR
6.3 TALEN
6.4 ZFN
6.5 ANTISENSE
6.6 OTHERS
7 GLOBAL GENE EDITING MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 GENETIC ENGINEERING
7.3 GENE THERAPY
7.4 CELL LINE ENGINEERING
7.5 OTHERS
8 GLOBAL GENE EDITING MARKET, BY END USER
8.1 OVERVIEW
8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
9 GLOBAL GENE EDITING MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 INDIA
9.4.3 JAPAN
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL GENE EDITING MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL GENE EDITING MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT EXPANSION AND LAUNCH
10.6.2 AGREEMENT/COLLABORATION
10.7 FINANCIAL MATRIX
10.7.1 SALES (USD MILLION), 2021
10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021
11 COMPANY PROFILES
11.1 BIO-RAD LABORATORIES, INC
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 GE HEALTHCARE
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 GENSCRIPT
11.3.1 COMPANY OVERVIEWS
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 INTEGRATED DNA TECHNOLOGIES, INC
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 NEW ENGLAND BIOLABS
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 SANGAMO THERAPEUTICS
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 THERMO FISHER SCIENTIFIC, INC
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 LONZA
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 HORIZON DISCOVERY LTD
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 ORIGENE TECHNOLOGIES, INC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
TABLE 3 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 36
TABLE 4 GLOBAL GENE EDITING MARKET, FOR CRISPR, BY REGION, 2019-2030 (USD MILLION) 36
TABLE 5 GLOBAL GENE EDITING MARKET, FOR TALEN, BY REGION, 2019-2030 (USD MILLION) 37
TABLE 6 GLOBAL GENE EDITING MARKET, FOR ZFN, BY REGION, 2019-2030 (USD MILLION) 37
TABLE 7 GLOBAL GENE EDITING MARKET, FOR ANTISENSE, BY REGION, 2019-2030 (USD MILLION) 37
TABLE 8 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION) 38
TABLE 9 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 41
TABLE 10 GLOBAL GENE EDITING MARKET, FOR GENETIC ENGINEERING, BY REGION, 2019-2030 (USD MILLION) 41
TABLE 11 GLOBAL GENE EDITING MARKET, FOR GENE THERAPY, BY REGION, 2019-2030 (USD MILLION) 42
TABLE 12 GLOBAL GENE EDITING MARKET, FOR CELL LINE ENGINEERING, BY REGION, 2019-2030 (USD MILLION) 42
TABLE 13 GLOBAL GENE EDITING MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD MILLION) 42
TABLE 14 GLOBAL GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 45
TABLE 15 GLOBAL GENE EDITING MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2019-2030 (USD MILLION) 45
TABLE 16 GLOBAL GENE EDITING MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2030 (USD MILLION) 46
TABLE 17 GLOBAL GENE EDITING MARKET, FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019-2030 (USD MILLION) 46
TABLE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2019-2030 (USD MILLION) 47
TABLE 19 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 50
TABLE 20 NORTH AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 51
TABLE 21 NORTH AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 51
TABLE 22 NORTH AMERICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 51
TABLE 23 US: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 52
TABLE 24 US: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 52
TABLE 25 US: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 52
TABLE 26 CANADA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 53
TABLE 27 CANADA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 53
TABLE 28 CANADA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 53
TABLE 29 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 55
TABLE 30 EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 56
TABLE 31 EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 56
TABLE 32 EUROPE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 57
TABLE 33 GERMANY: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 57
TABLE 34 GERMANY: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 58
TABLE 35 GERMANY: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 58
TABLE 36 FRANCE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 58
TABLE 37 FRANCE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 59
TABLE 38 FRANCE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 59
TABLE 39 UK: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 59
TABLE 40 UK: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 60
TABLE 41 UK: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 60
TABLE 42 ITALY: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 60
TABLE 43 ITALY: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 61
TABLE 44 ITALY: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 61
TABLE 45 SPAIN: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 61
TABLE 46 SPAIN: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 62
TABLE 47 SPAIN: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 62
TABLE 48 REST OF EUROPE: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 62
TABLE 49 REST OF EUROPE: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 63
TABLE 50 REST OF EUROPE: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 63
TABLE 51 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 65
TABLE 52 ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 65
TABLE 53 ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 66
TABLE 54 ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 66
TABLE 55 CHINA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 67
TABLE 56 CHINA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 67
TABLE 57 CHINA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 68
TABLE 58 INDIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 68
TABLE 59 INDIA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 68
TABLE 60 INDIA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 69
TABLE 61 JAPAN: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 69
TABLE 62 JAPAN: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 70
TABLE 63 JAPAN: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 70
TABLE 64 AUSTRALIA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 71
TABLE 65 AUSTRALIA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 71
TABLE 66 AUSTRALIA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 71
TABLE 67 SOUTH KOREA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 72
TABLE 68 SOUTH KOREA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 72
TABLE 69 SOUTH KOREA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 72
TABLE 70 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 73
TABLE 71 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 73
TABLE 72 REST OF ASIA-PACIFIC: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 73
TABLE 73 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2019-2030 (USD MILLION) 75
TABLE 74 REST OF THE WORLD: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 75
TABLE 75 REST OF THE WORLD: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 76
TABLE 76 REST OF THE WORLD: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 76
TABLE 77 MIDDLE EAST: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 77
TABLE 78 MIDDLE EAST: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 77
TABLE 79 MIDDLE EAST: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 77
TABLE 80 AFRICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 78
TABLE 81 AFRICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 78
TABLE 82 AFRICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 78
TABLE 83 LATIN AMERICA: GENE EDITING MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 79
TABLE 84 LATIN AMERICA: GENE EDITING MARKET, BY APPLICATION, 2019-2030 (USD MILLION) 79
TABLE 85 LATIN AMERICA: GENE EDITING MARKET, BY END USER, 2019-2030 (USD MILLION) 79
TABLE 86 MAJOR PLAYERS IN THE GLOBAL GENE EDITING MARKET 80
TABLE 87 MOST ACTIVE PLAYER IN THE GLOBAL GENE EDITING MARKET 82
TABLE 88 PRODUCT EXPANSION AND LAUNCH: GLOBAL GENE EDITING MARKET 83
TABLE 89 AGREEMENT/COLLABORATION: GLOBAL GENE EDITING MARKET 84
TABLE 90 BIO-RAD LABORATORIES, INC: PRODUCTS OFFERED 87
TABLE 91 GE HEALTHCARE: PRODUCTS OFFERED 90
TABLE 92 GENSCRIPT: PRODUCTS OFFERED 93
TABLE 93 GENSCRIPT: KEY DEVELOPMENTS 93
TABLE 94 INTEGRATED DNA TECHNOLOGIES, INC: PRODUCTS OFFERED 95
TABLE 95 INTEGRATED DNA TECHNOLOGIES, INC: KEY DEVELOPMENTS 96
TABLE 96 NEW ENGLAND BIOLABS: PRODUCTS OFFERED 97
TABLE 97 SANGAMO THERAPEUTICS: PRODUCTS OFFERED 100
TABLE 98 SANGAMO THERAPEUTICS: KEY DEVELOPMENTS 100
TABLE 99 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 103
TABLE 100 LONZA: PRODUCTS OFFERED 106
TABLE 101 LONZA: KEY DEVELOPMENTS 106
TABLE 102 HORIZON DISCOVERY LTD: PRODUCTS OFFERED 107
TABLE 103 HORIZON DISCOVERY LTD: KEY DEVELOPMENTS 107
TABLE 104 ORIGENE TECHNOLOGIES, INC: PRODUCTS OFFERED 109
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 15
FIGURE 2 GLOBAL GENE EDITING MARKET 16
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL GENE EDITING MARKET 25
FIGURE 5 DRIVER IMPACT ANALYSIS 27
FIGURE 6 RESTRAINT IMPACT ANALYSIS 28
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL GENE EDITING MARKET 29
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL GENE EDITING MARKET 31
FIGURE 9 GLOBAL GENE EDITING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, (USD MILLION) 35
FIGURE 10 GLOBAL GENE EDITING MARKET, BY TECHNOLOGY, 2022 & 2030 (USD MILLION) 35
FIGURE 11 GLOBAL GENE EDITING MARKET SHARE (%), BY TECHNOLOGY, 2022 36
FIGURE 12 GLOBAL GENE EDITING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD MILLION) 40
FIGURE 13 GLOBAL GENE EDITING MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 40
FIGURE 14 GLOBAL GENE EDITING MARKET SHARE (%), BY APPLICATION, 2022 41
FIGURE 15 GLOBAL GENE EDITING MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 43
FIGURE 16 GLOBAL GENE EDITING MARKET, BY END USER, 2022 & 2030 (USD MILLION) 44
FIGURE 17 GLOBAL GENE EDITING MARKET SHARE (%), BY END USER, 2022 45
FIGURE 18 GLOBAL GENE EDTING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 47
FIGURE 19 GLOBAL GENE EDITING MARKET SHARE (%), BY REGION, 2022 48
FIGURE 20 NORTH AMERICA MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 49
FIGURE 21 NORTH AMERICA: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 50
FIGURE 22 NORTH AMERICA: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 50
FIGURE 23 EUROPE MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 54
FIGURE 24 EUROPE: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 55
FIGURE 25 EUROPE: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 56
FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 64
FIGURE 27 ASIA-PACIFIC: GENE EDITING MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 64
FIGURE 28 ASIA-PACIFIC: GENE EDITING MARKET SHARE (%), BY COUNTRY, 2022 65
FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: GENE EDITING MARKET, 2019-2030 (USD MILLION) 74
FIGURE 30 REST OF THE WORLD: GENE EDITING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 74
FIGURE 31 REST OF THE WORLD: GENE EDITING MARKET SHARE (%), BY REGION, 2022 75
FIGURE 32 BENCHMARKING OF MAJOR COMPETITORS 81
FIGURE 33 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL GENE EDITING MARKET 82
FIGURE 34 GLOBAL GENE EDITING MARKET: COMPETITIVE LANDSCAPE 83
FIGURE 35 SALES 2021 84
FIGURE 36 RESEARCH & DEVELOPMENT EXPENDITURE, 2021 85
FIGURE 37 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT 87
FIGURE 38 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS 88
FIGURE 39 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 90
FIGURE 40 GE HEALTHCARE: SWOT ANALYSIS 91
FIGURE 41 GENSCRIPT: FINANCIAL OVERVIEW SNAPSHOT 92
FIGURE 42 GENSCRIPT: SWOT ANALYSIS 94
FIGURE 43 SANGAMO THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT 99
FIGURE 44 SANGAMO THERAPEUTICS: SWOT ANALYSIS 101
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 103
FIGURE 46 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 104
FIGURE 47 LONZA: FINANCIAL OVERVIEW SNAPSHOT 105
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security